Ruth Holm

Experimental Pathology

Group Leader: Ruth Holm Ph.D.

The research work of our group include gynaecological cancers and cell cycle-, apoptosis- and cell adhesion-markers, matrix metalloproteinases and HPV.

In addition to our own projects we are doing research work for other departments at Rikshospitalet-Radiumhospitalet Medical Center (RRMC) as well as for other hospitals.

Research projects

Molecular mechanisms in development and progression of ovarian cancers.

Molecular mechanisms in development and progression of vulvar cancers.

Print this page [144 visits]

News & events

University of Oslo's Research Prize to Johan Moan
Jul 19, 2010

JAMA article first-authored by Philip Wilkens
Jul 6, 2010

Sir Hans Krebs Medal to Harald Stenmark
Jul 6, 2010

Paper from Anne-Lise Børresen-Dale and co-workers published in "Science Translational Medicine"
Jun 30, 2010

Sandvig group with review article in "Nanomedicine"
Jun 25, 2010

More news

Latest publications

Ruth Holm

Wang Z, He W, Yang G, Wang J, Wang Z, Nesland JM, Holm R, Suo Z (2010)
Decreased expression of GST pi is correlated with a poor prognosis in human esophageal squamous carcinoma
BMC Cancer, 10, 352
PubMed 20602752

Wang Z, Trope CG, Flørenes VA, Suo Z, Nesland JM, Holm R (2010)
Overexpression of CDC25B, CDC25C and phospho-CDC25C (Ser216) in vulvar squamous cell carcinomas are associated with malignant features and aggressive cancer phenotypes
BMC Cancer, 10, 233
PubMed 20500813

Evang JA, Borota OC, Melum E, Holm R, Ramm-Pettersen J, Bollerslev J, Berg JP (2010)
HDAC2 expression and variable number of repeats in exon 1 of the HDAC2 gene in corticotroph adenomas
Clin Endocrinol (Oxf), 73 (2), 229-35
PubMed 20346000

More publications